Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Exhaled Breath Particles as a Clinical Indicator for Acute and Chronic Rejection After Lung Transplantation

NCT05375149 is registered in ClinicalTrials.gov with Lund University Hospital as lead sponsor.

NCT NCT05375149
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05375149 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Exhaled Breath Particles as a Clinical Indicator for Acute and Chronic Rejection After Lung Transplantation
Lead sponsor
Lund University Hospital
Phase
Observational
Overall status
Recruiting
Start date
September 18, 2018
Completion date
September 30, 2026
Enrollment
150 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic rejection of lung transplant, lung transplant rejection, primary graft dysfunction